Abstract
Clostridium perfringens type E disease in ruminants has been characterized by hemorrhagic enteritis or sudden death. Although type E isolates are defined by the production of alpha and iota toxin, little is known about the pathogenesis of C. perfringens type E infections. Thus far, the role of iota toxin as a virulence factor is unknown. In this report, iota toxin showed positive effects on adherence and colonization of C. perfringens type E while having negative effect on the adherence of type A cells. In-vitro and in-vivo models suggest that toxinotype E would be particularly adapted to exploit the changes induced by iota toxin in the surface of epithelial cells. In addition, type E strains produce metabolites that affected the growth of potential intra-specific competitors. These results suggest that the alteration of the enterocyte morphology induced by iota toxin concomitantly with the specific increase of type E cell adhesion and the strong intra-specific growth inhibition of other strains could be competitive traits inherent to type E isolates that improve its fitness within the bovine gut environment.
Introduction
Clostridium perfringens, a Gram positive, anaerobic and spore forming bacteria, is widely distributed in nature and considered an important pathogen of both human and livestock [1]. Isolates are classified into five toxinotypes (A to E) based upon production of four major toxins (alpha, beta, epsilon, and iota) [2]. C. perfringens type E isolates are defined by the production of alpha and iota toxin, although additional potential virulence genes encoding beta2-toxin, urease or lambda-toxin can be also found in some isolates [3]. Type E isolates cause enteritis or enterotoxaemia in rabbits [4], lambs [2], cattle [5, 6, 7], goats [8] and dogs [1]. C. perfringens type E disease in ruminants is characterized by hemorrhagic enteritis or sudden death and has been described in ovine and bovines. Lesions observed at necropsy are hyperemia and edema in the mucosa of intestine and abomasum, with foci of hemorrhage, acute inflammation and submucosal edema [6, 7]. Since first description more than 50 years ago [8], toxinotype E has been considered an uncommon cause of enteritis in calves [9] although this toxinotype could be more common than previously considered [6, 7, 10].
Information available about type E pathogenesis is scarce, but it is generally accepted that iota toxin (ITX) is the main virulence factor of C. perfringens type E isolates [6, 11]. ITX belongs to the binary toxin family which is composed of two unlinked protein, an enzymatic component with ADP-ribosyltransferase activity and a binding component which binds to the cell surface receptor [12, 13] and facilitates the enzymatic component entry into the cytosol [14, 15]. Besides ITX, other binary toxins are codified by Clostridium spp. strains that produce intestinal diseases as diarrhea and enteritis including C. botulinum C2 toxin [16], C. spiroforme iota-like toxin [17] and C. difficile ADP-ribosyltransferase [18]. Cellular intoxication by binary toxins has been extensively studied and most recent reports suggest that actin depolymerization induced by C. difficile´s binary toxin triggers the formation of microtubule-based protrusions at the apical side of cells, and reroutes secretory vesicles containing extracellular matrix proteins like fibronectin from basolateral to the apical surface of host cells. Eventually, secreted fibronectin and the microtubule-based meshwork increase the adherence of clostridia [19, 20]. Currently, the amount of information regarding the ability of C. perfringens strains to adhere to epithelial cells is limited [21, 22].
In natural cases of hemorrhagic enteritis produced by C. perfringens type E, a clonal predominance among isolates from affected animals has been observed [7, 23]. In contrast, a high degree of genetic diversity is usually found in C. perfringens strains obtained from healthy animals. These observations together with the multilocus sequence typing (MLST) analysis of type E isolates from diverse geographical regions suggest that toxinotype E has specialized to succeed in a particular ecological niche, such as the bovine gut. Also, recent evidence shows that some C. perfringens are able to produce bacteriocins to inhibit other C. perfringens strains growth [24, 25], suggesting that intra-specific inhibition could be an important mechanism involved in the clonal predominance observed in C. perfringens type E enteritis.
In this work, we observed that C. perfringens type E strains produce metabolites other than ITX which affect the growth of potential competitors, while ITX induces modifications on epithelial cells that increase the adherence of type E strains while having negative effect on the adherence of other C. perfringens strains. Both effects seem to be important to increase the relative fitness of type E strains within the intestinal environment.
Materials and Methods
Bacterial strains and culture conditions
Two field isolates of C. perfringens type E (CpE218 and CpE132) obtained during two outbreaks of hemorrhagic enteritis in cattle [7], and two type A strains isolated from healthy cattle (Cp31 and Cp88) were used in the present study. Additional information about the strains is presented in Table 1. C. perfringens isolates were plated in blood agar plates directly from the freezer stock and incubated overnight at 37°C under anaerobic conditions. For the purposes of this study, single colonies were cultured in 10 ml of BHI broth in individual tubes overnight at 37°C in anaerobic chambers. To choose the most effective selective media for subsequent tests, bacterial cultures were then spread on individual blood agar plates containing neomycin (100 μg/ml) [26] with or without nalidixic acid (25 μg/ml). The identity of the colonies was confirmed by biochemical tests and multiplex PCR [27].
Table 1. Strains used in this study.
Strain | Type | Genotype | Host specie | Origin |
---|---|---|---|---|
Cp31 | A | cpa | Bovine | Healthy |
Cp88 | A | cpa | Bovine | Healthy |
Cp132 | E | cpa, cpe, cpb2, iA | Bovine | Hemorraghic enteritis |
CpE218 | E | cpa, cpe, cpb2, iA | Bovine | Hemorraghic enteritis |
Growth curves
0.1 ml of overnight cultures prepared as mentioned above was used to inoculate 10 ml of fresh BHI and incubated at 37°C under anaerobic conditions. Aliquots were taken every 2 h and the optical density was measured at 600 nm. The final value was taken as the average of three independent measurements [28].
Caco-2 cell culture
Human-derived enterocyte-like Caco-2 cells were cultured in Eagle’s MEM supplemented with heat-inactivated 10% fetal calf serum, 1% non-essential amino acids, 1% glutamine, penicillin-streptomycin (100 IU/ml and 100 μg/ml respectively) in a humidified atmosphere containing 5% CO2 at 37°C. For adhesion assays, the Caco-2 cells were cultured until confluence and then further cultivated for 7–10 days to obtain differentiated cells [22]. Caco-2 cells medium was replaced with antibiotic-free medium for 24 h to perform the adhesion assay.
Agar spot on lawn assays
This method was used for screening inhibitory activity between C. perfringens isolates. Selected strains were cultured until the late stationary phase and diluted with fresh BHI to reach a density of 0.5 in McFarland scale. Bacterial suspension was spread on a BHI agar plate to form a homogeneous lawn. Another aliquot of the same culture was centrifuged at 13,000 g for 10 min to pull down bacteria and supernatants were collected and filter sterilized with 0.45 μm filters. Inoculated plates were allowed to dry for a few minutes and a drop of the filtered supernatants was placed over. Inhibitory abilities were tested in a chessboard fashion after incubation at 37°C in anaerobic atmosphere [25].
Characterization of the antimicrobial soluble factor
Ammonium sulphate-concentrated C. perfringens Type E cell-free supernatant was used to test thermal and protease stability of the antimicrobial soluble factor. The remaining antibacterial activity after heat and protease treatment was determined by the agar spot test using dilutions of the treated supernatant and compared with the activity of the corresponding control (= 100%). Thermal stability was evaluated by determination of the residual antibacterial activity after incubation at 4, 24, 37, 42, 60, 80 and 100°C for 10, 30 and 60 min. Effect of trypsin, papain and proteinase K on antimicrobial activity was also tested. Each enzyme was prepared at a concentration of 10 mg/ml and added to the concentrated supernatant at a final concentration of 1 mg/ml. After incubation for 1 h at 37°C, the inhibitory activity was determined.
Inhibition assays in liquid medium
Overnight cultures of C. perfringens type E (CpE218 strain) and C. perfringens type A (Cp88 strain) were diluted and inoculated into 10 ml of BHI broth (inhibitor/target ratio 1:10; that is, type E bacteria [1x106 CFU/ml] to type A bacteria [1x107 CFU/ml]). The same amount of type A bacteria was individually inoculated into 10 ml of BHI broth as control (monoculture). Another co-culture with a nalidixic acid sensitive type A strain (Cp31), which did not show inhibitory effect over the Cp88 strain, was prepared identically as Cp88+CpE218 mix and included as an additional control. All three cultures were incubated under anaerobic conditions at 37°C for 24 h and samples were collected at different time points (2, 4, 6 and 24 h). Samples were serially diluted and placed on blood agar plates supplemented with neomycin (100 mg/L) and nalidixic acid (25 mg/L). Blood agar plates supplemented with neomycin and nalidixic acid only allow Cp88 strain (type A) growth. Therefore this selective media was used for nalidixic acid resistant CFU counts in further described co-culture assays. Plates were cultured overnight at 37°C under anaerobic conditions. Colonies in each of the plates were counted and expressed as CFU/ml. Also at mentioned time intervals, OD600 of each culture was determined to evaluate total clostridia. Identity of the colonies and selective media specificity were confirmed by multiplex PCR [27].
Competitive exclusion and strain displacement in a cell model
For competitive exclusion assays, Caco-2 cells monolayers were infected with a bacterial suspension. One ml of a stationary phase culture of each strain was centrifuged at 13.000 g for 5 min and washed 3 times with sterile PBS. Pellet was re-suspended in fresh MEM to get a final concentration of 1x106 CFU of type E strain (CpE 218) and 1x107 CFU of type A strain (Cp88) (inhibitor/target ratio 1:10). For competitive exclusion assay both strains were added simultaneously and incubated for 2 h in aerobic atmosphere. For displacement assay, type A bacteria suspension was added first to cell monolayer and allowed to attach for 2 h, washed 3 times with PBS to remove unattached bacteria and then type E bacteria suspension was added and incubated for another hour. After incubation, in both experiments, each well was washed 3 times with sterile PBS to remove no adhered bacteria. Sterile distilled water was added for 15 minutes to lyse the Caco-2 cells and recover attached bacteria. Finally, C. perfringens nalidixic acid resistant CFU number was determined as mentioned above.
Iota toxin
ITX was purified as described by Stiles [29]. Briefly, cell-free supernatant proteins were precipitated by adding a saturated solution of ammonium sulphate (4°C) up to 70% saturation. Precipitate was collected 18 h later by centrifugation (7,000 g for 20 min), dissolved in 10 mM Tris-HCl buffer, pH 7.5 and dialyzed with the same buffer to remove residual ammonium sulphate. For ITX purification, concentrated supernatant was applied to a DEAE-Sepharose CL-6B column previously equilibrated with 10 mM Tris-HCl buffer, pH 7.5. Both fractions of ITX were eluted with a 0.0 to 0.2 M NaCl linear gradient. The final ITX purity, as assessed by densitometry of a 12% SDS/PAGE followed by Coomassie Blue staining, was >95%. Activity was tested using cytotoxicity test on Caco-2 cell monolayers [13].
In vitro adhesion to Caco-2 cells assays
Washed bacteria were used to infect cell monolayers; 1 ml of a stationary phase culture of each strain was centrifuged at 13.000 g for 5 min and washed 3 times with sterile PBS. Pellet was resuspended in fresh MEM to get a final concentration of 1.5 x 107 CFU of C. perfringens, which was added to cells monolayer to determine adhesive properties of each strain. Infected cells were incubated in a humidified atmosphere containing 5% CO2 at 37°C for 2 h. Cell monolayers were washed 3 times with sterile PBS to remove unattached bacteria. Then, Caco-2 cells were disrupted by distilled water immersion for 15 min and the amount of bounded bacteria was estimated by colony counting on neomycin blood agar plates (CFU/ml) after overnight incubation at 37°C under anaerobic conditions. Adherence was expressed as the percentage of attached bacteria to the cell monolayer relative to the total number of added bacteria. First, the effect of ITX on type E bacteria (strain CpE218) adherence was evaluated in Caco-2 cells treated with different concentrations of purified ITX for 2 h previous to infection with bacteria suspension. Changes in adherence of type E bacteria were quantified as the percentage of adherence relative to control cell monolayer. To test if ITX mediated changes in clostridia adherence are specific for type E bacteria, type E (CpE218) and type A (Cp88 and Cp31) bacterial adherence were evaluated after treat Caco-2 cells with 150 ng/ml Ia and 300 ng/ml Ib, changes in adherence were quantified as mentioned before.
Neutralization of iota toxin induced changes in clostridia adherence
To test if ITX was responsible for the observed changes in clostridia adherence to Caco-2 cells, antibody neutralization experiments were performed. For these experiments anti-ITX IgY antibodies were obtained as previously described [30] using ITX antigen. Purified ITX (150 ng/ml Ia and 300 ng/ml Ib) solution was mixed with a solution containing ITX-neutralizing IgY antibody or negative control IgY. Mixtures were then incubated for 30 min at room temperature. Adherence assays were performed as described before using type E and type A strains on Caco-2 cells monolayers non-treated, treated with ITX or with ITX + antibodies, Changes in adherence were quantified as the percentage of adherence relative to control cell monolayer (non-treated).
Scanning electron microscopy
After ITX treatment and C. perfringens infection, Caco-2 cell culture medium was replaced by ice-cold cacodylate buffer (0.1 M cacodylate, 0.01 M CaCl2, 0.01 M MgCl2, 0.09 M saccharose, pH 6.9) and prefixed by adding paraformaldehyde to a final concentration of 5%. After 10 min glutaraldehyde was added to a final concentration of 2%. Cells were dehydrated by incubation in a graded series of ethanol in 10% steps up to 100%, critical-point dried with liquid CO2 (EMS 850 Critical Point Drier de Electron Microscopy Sciences.) and covered with a thin palladium-gold (60–40%) film for conductivity by sputter coating (SC7620 Mini Sputer Coater de Thermo VG Scientific). Samples were examined in a field emission scanning electron microscope DSM982 Gemini at an acceleration voltage of 5 kV.
Mice experiments
Conventionally reared male Swiss mice (20–25 g body weight) were used for in-vivo adhesion and displacement assays. Overnight cultures of C. perfringens type A (Cp88) and type E (Cp218) were prepared as mentioned before. Mice were fasted for 4 h with free access to water until 1 h before the beginning of the experiment. For adhesion assays, groups of four mice were inoculated intragastrically with 0.2 ml of C. perfringens cultures, containing approximately 1 x 107 CFU of strain CpE218 or Cp88. Inoculated mice were monitored for the onset, duration and outcome of colonization by serial culture of fecal pellets in neomycin blood agar plates in anaerobic conditions at 37°C. For displacement assays, groups of four mice were inoculated intragastrically with 0.2 ml of C. perfringens cultures, containing approximately 1 x 106 CFU of strain CpE218 and 1 x 107 CFU of strain Cp88 (inhibitor/target ratio 1:10). Inoculated mice were monitored for the onset, duration and outcome of colonization by serial culture of fecal pellets in neomycin and nalidixic acid blood agar plates in anaerobic conditions at 37°C. At the end of the observation period, euthanasia was performed. Postmortem examinations were performed immediately after death on all the animals from each group. The gastrointestinal tract was collected and fixed by immersion in 10% formalin at pH 7.2 for a minimum of 24 h before being processed routinely to obtain 4 μm thick sections. Tissue sections were prepared and stained either with H&E or used for immunohistochemistry (IHC).
Institutional Animal Care and Use Committee (IACUC) Approval
Studies presented here were reviewed and approved by the Comité Institucional para el cuidado y uso de animales de experimentación (IACUC) from the CICVyA-INTA, under protocols 32/2010 and 27/2011.
Statistical analyses
Statistical analyses were performed using GraphPad Prism 5.0 software. Strain comparison at individual time points was performed by one-way ANOVA. To assess the overall trends of growth and the corresponding phenotypic traits over the time-course, area under curve (AUC) analysis was performed for each strain and strains were then compared by one-way ANOVA. Student’s t test was used when two groups of data had to be compared and Friedman test was used when more than two groups had to be compared. P values <0.05 were considered statistically significant.
Results
C. perfringens type A strains are inhibited by a type E soluble factor
Growth of selected strains (Table 1) was determined in order to rule out intrinsic growth differences between these strains that could interfere with results of subsequent experiments. Similar in-vitro growth rates (P>0.05) were calculated for these type A and type E strains (Fig. 1). Filter sterilized supernatants of type A and type E strains were tested for inhibitory activity. Both type E strains were able to inhibit tested type A strains (Fig. 2) but differences between inhibitory activities of type E strains were observed. CpE218 strain showed higher inhibitory effects than CpE132 and was also able to inhibit this last one (data not shown). None of the type A strains showed inhibitory activity against other type A or type E strains. Studies were made in an attempt to define the nature of the inhibitor factor. After treating type E supernatants 30 min at 80°C and 10 min at 100°C, inhibitory activity against C. perfringens type A strains (Cp31 and Cp88) was no longer present. A significant reduction in inhibitory activity was observed after treatment with trypsin (P<0.05) and proteinase K (P<0.05), while treatment of concentrated supernatants with papain did not reduce inhibitory activity (P>0.05). Heat inactivation and susceptibility to proteolitic enzymes suggest a proteinaceous nature of the detected inhibitory factor. Results are summarized on Table 2.
Table 2. Effects of enzymes and heat on type E antimicrobial activity.
Treatment | Activity a (%) |
---|---|
Control | 100 |
Trypsin | 35 |
Proteinase K | 25 |
Papain | 100 |
Temperature (time) | |
4 (60 min) | 100 |
24 (60 min) | 100 |
37 (60 min) | 100 |
42 (60 min) | 100 |
60 (60 min) | 100 |
80 (30 min) | 0 |
100 (10 min) | 0 |
a Activity is the remaining antimicrobial activity expressed as percentage of the control.
C. perfringens type E strains inhibit the growth of type A strains in co-culture
When nalidixic acid resistant type A strain (Cp88) was co-cultured with nalidixic acid sensible type A or type E strains in BHI broth, no significant differences in optical density (OD600) were observed (P>0.05). These results suggest that total clostridia cell density was similar in monoculture and co-cultures (Fig. 3A). Experiments with nalidixic acid resistant type A and type E strains showed no significant differences between monoculture and co-cultures in counts of nalidixic acid resistant CFU after 2 h of anaerobic culture (P>0.05). In contrast, after 4 h of co-culture of type A and type E strains, counts of nalidixic acid resistant CFU were significantly lower when compared to monoculture of type A (Cp88) strain (P<0.001) (Fig. 3B). At 24 h, CFU count of nalidixic acid resistant type A strain (Cp88) in co-culture with type E strain was 6 times lower compared with monoculture (P<0.001). Co-culture with the nalidixic acid sensitive type A strain (Cp31), which did not show inhibitory effect over the Cp88 strain, produced a reduction in nalidixic acid resistant CFU count at 4 h, but these differences were not statistically significant (P>0.05). This may suggest that the effect of a non-specific mechanism like nutrient consumption or quorum sensing response. All the results are expressed in comparison with nalidixic acid resistant type A strain (Cp88) grown in monoculture. Multiplex PCR assays probed that nalidixic acid resistant colonies were only type A and confirmed the specificity of the selective plating protocol.
Type E clostridia reduce type A cell adhesion
Competitive inhibition and displacement between both strains were examined in adhesion assays on Caco-2 cells monolayers. When both strains were added at the same time, a reduction in attached type A bacteria was observed as determined by nalidixic acid resistant CFU counts compared with controls (P< 0.0001) (Fig. 4A). The addition of type A Cp31 strain without inhibitory effect, caused a slight reduction in nalidixic acid resistant CFU counts which was not statistically significant (P>0.05). In displacement assays (Fig. 4B), type A clostridia were first allowed to attach to Caco-2 cells for 2 h before the addition of type E clostridia. These displacement assays showed that type E is not able to displace significantly (P>0.05) the cell-attached type A clostridia. After increasing the relative number of type E cells (inhibitor/target ratio 1:2) it was possible to observe a significant decrease in nalidixic acid resistant CFU counts (P<0.05). The addition of another type A strain (Cp31) without inhibitory effect, did not show significant effect on displacement assays in any of the tested ratios (P>0.05). Multiplex PCR assays confirmed that nalidixic acid resistant colonies were only type A and confirmed the specificity of the selective plating protocol.
Iota toxin increases type E adherence while decreases type A adherence
Since previous reports have shown that ITX increases adhesion of bacteria to eukaryotic cells [19], differences in adherence between type E and type A strains and the influence of ITX were analyzed. The average percentage of adherence of C. perfringens type A and type E were 76.3% and 35.5% respectively, which suggest that type A strains bind more effectively to Caco-2 cells than type E strains. However, treatment of monolayers with ITX increased the number of type E bacteria attached to cells in a dose dependent manner (Fig. 5A). Comparative adhesion assay between type E and type A strains, shows about a 2 fold increase in enterocyte-bounded type E clostridia after treatment with ITX, as compared to untreated controls (P<0.0001) (Fig. 5B). A 58.4% and 52% reduction was observed in bacterial adhesion values for type A strains Cp88 and Cp31 as compared with controls (P<0.001). To definitively evaluate whether observed adherence changes were ITX-mediated neutralization experiments were performed. Preincubation of ITX with IgY anti-ITX neutralized the changes of type A and type E strains adherence on Caco-2 cells (P<0.05) (Fig. 5C). A control of IgY obtained from non-immunized animals was not able to avoid the observed effects (data not shown). Scanning electron microscopy studies revealed that attached bacteria were not homogeneously distributed but forming small aggregates on both treated and control monolayers (Fig. 6), which may hinder bacterial counts. However, type E bacteria attached to surface protrusions were observed in ITX treated monolayers. These protrusions were not observed in these control cells, although some few bacteria were attached to cells surface of non-treated cells.
C. perfringens type E bacteria attach to small intestinal mucosa
In order to evaluate if the adherence of C. perfringens type E to Caco-2 cells is also reproduced in epithelial cells in vivo, mice were infected with both toxinotypes. After challenge with type E (CpE218) and type A (Cp88) strains, none of the challenged mice developed clinical signs during the examination period. Onset of C. perfringens colonization was determined by periodic fecal cultures. Colonization onset after challenge with strains CpE218 or Cp88 was similar in both groups. Excretion of C. perfringens was detected in 60% of the inoculated animals during the first 24h. After two consecutive negative fecal cultures (48 h post challenge), mice were sacrificed. None of the animals exhibited gross lesions and no histological changes were observed in any of the challenged animals. Despite this, histological analysis of jejunum and ileum sections of type E challenged mice revealed many Gram positive rod shaped bacteria (Fig. 7B-C) and IHC confirmed the identity of the bacteria as C. perfringens (Fig. 8B). In type A challenged mice no attached bacteria compatible with C. perfringens were observed (Fig. 7A; Fig. 8A).
Type E bacteria reduce intestinal colonization by type A strains in-vivo
Inoculation of mice with CpE218 and Cp88 strains resulted in colonization of 60% of the mice. Extension of colonization was variable, ranging from 6 to 24 h after challenge. Mice intestinal colonization rate and colonization extension was similar for type E and type A strains (P>0.05). None of the mouse showed signs of disease or died during the observation period after the challenge. All negative control mice remained negative for C. perfringens bacteriology detection and showed no signs of disease throughout the observation period. When mice were challenged with a mix of type A and type E bacteria (10:1 ratio), type A colonization rate showed a significant reduction (30% vs. 60%). Also, it was possible to observe a reduction in the duration of intestinal colonization by type A clostridia (18 h vs. 2 h; P<0.005).
Discussion
C. perfringens type E has been identified as a pathogen associated with hemorrhagic enteritis and sudden death in ruminants [6, 7, 10]. Although numerous studies describe the mechanism involved in cell intoxication by iota toxin produced by C. perfringens type E strains, little is known about the pathogenesis of this toxinotype. Previous studies report a clonal relationship between different type E isolates obtained from a single diseased bovine and between isolates from diverse geographical locations, suggesting a clonal predominance and successful expansion of one type E clone within the bovine gut ecological niche [7, 23]. The results of the present study suggest that modifications on the cellular surface induced by iota toxin and the ability to inhibit the growth of competitor C. perfringens strains could be at least some of the mechanisms implied in the initials stages of gut invasion by type E bacteria and the development of clonal sub-populations.
Bacterial species that comprise highly diverse communities, as the intestinal microbiota, are often engaged in a fierce arms race over resources and space. The importance of intra-specific inhibition as a pathogenic strategy for some C. perfringens has been postulated for strains producing necrotic enteritis in poultry since clonal dominance of pathogenic over commensal strains has been observed [24, 31]. The results of the present report show that the observed intra-species inter-strain growth inhibition caused by type E C. perfringens is mediated by a bacteriocin-like substance secreted by the bacterium into its microenvironment. Heat inactivation and susceptibility to proteolitic enzymes suggest a proteinaceous nature of this inhibitory factor, although further characterization is needed. It is known that all the C. perfringens toxinotypes are able to produce bacteriocins that can affect other C. perfringens strains [32]. Timbermont et al. [24] and Watson et al. [33] reported that most strains implicated in poultry necrotic enteritis (46%) and human food poisoning (79%) outbreaks respectably produced some kind of bacteriocins; however, only 15% of isolates from healthy chickens and 18% from healthy persons produced bacteriocins, suggesting a relationship between bacteriocin production and the ability to cause intestinal disease in humans and animals.
Bacteriocins are substances commonly involved in intra-species growth inhibition [25]. The dominant reason for bacteria to produce bacteriocins is to provide the producing organism with an ecological advantage over its most likely competitors [34]. Bacteriocins are proteinaceous toxins that facilitate their producing organisms to defend their habitat against invaders, limit the advance of neighbouring cells [35] or invade an established bacterial community [36, 37]. Therefore, the production of bacteriocins by C. perfringens type E (and probably others toxinotypes) could be important to improve their survival within the intestinal environment either defending their space from other strains or invading an established environment. Our in- vitro experiments showed that only a high proportion of C. perfringens type E could displace established type A cells, suggesting a defensive role for bacteriocins in the intestinal environment for type E strains.
Similar to C. perfringens type E and the iota toxin, C. spiroforme causes diarrheic deaths that are spontaneous or antibiotic induced in rabbits [11] and perhaps in humans [38], via a binary iota-like toxin referred to as CST. Closely related to the iota toxin and CST is the iota-like toxin produced by C. difficile (CDT) [18]. The protein components of these toxins are interchangeable, thus generating biologically active chimeras that demonstrate conserved functionality among these clostridial species [39]. Interestingly C. difficile, C. perfringens, and C. spiroforme are all associated with gastrointestinal diseases in humans as well as in animals [1, 2] and the synthesis of common binary toxins with interchangeable protein components probably reveals a shared evolutionary path for these ubiquitous pathogens in a common niche. The actin-ADP-ribosylating binary toxins of clostridia, not only affect the actin cytoskeleton and induce the formation of microtubule based extensions, but induce a vesicle rerouting with the consequent secretion of extracellular matrix proteins like fibronectin to increase bacterial adherence [19, 20]. We have observed similar changes at the enterocyte surface of cultured cells induced after iota toxin incubation that resulted in an increased adherence of C. perfringens type E bacteria. However, we found that this cellular alteration could be a disadvantage for non-producing iota toxin strains, suggesting that type E strains codify not only for iota-toxin but specific factors of adherence to this meshwork of microtubule based structures and extracellular matrix proteins.
In order to understand how type E strains could deal with type A strains in the intestinal environment, mice were first inoculated with both strains separately. Colonization was observed in mice by either C. perfringens type A or type E inoculation. A comparable pattern of C. perfringens type E adherence to cultured epithelial cells altered by iota toxin was also detected in the epithelium of the gastrointestinal tract of mice challenged with this toxinotype but no with others. Also, we detected a comparable distribution and sort of adherence of C. perfringens in the gastrointestinal tract of bovines with natural C. perfringens type E disease [7], suggesting that type E also induced these epithelial alteration and attachment in ruminants gut. In mice inoculated with type A and a minor fraction (10:1) of type E clostridia, type colonization was significantly reduced. The experiments with mice suggest that type E has the ability to inhibit other C. perfringens strains in-vivo and it would be an explanation for previous observation of clonal predominance [7, 23] and intra-specific inhibition of this toxinotype. Short times of fecal recovery of both strains may suggest an apparent negative competitive interaction between both strains. In well-mixed, unstructured environments (as the intestinal lumen) producers of weak bacteriocin-like activity are selectively advantageous and overcome producers of strong bacteriocin-like [40]. From our in-vitro results, we assume that type E produces a strong bacteriocin-like activity against the selected sensitive type A strain but this type A strain did not show any inhibitory activity against type E. A possible explanation for the mice result is that the strong inhibitory activity of type E strain eliminated type A cells but the relatively low proportion of type E cells was not able to overcome the rough intestinal environment and to multiply enough to be recovered by regular anaerobic culturing procedures. However, C. perfringens cells were observed attached to altered enterocytes in the small intestine of mice either if type E was or not co-administered with the sensitive type A strain. In contrast, attachment was not observed in animals inoculated only with several type A strains obtained from apparently healthy animals.
The ability of type E strains to colonize and create a structured environment seems to be important for the success of this toxinotype and constitutive strong bacteriocin production was probably acquired after this sessile lifestyle, protecting their space from invaders and improving the fitness of determined type E clones. Bacteriocinogenic bacteria are supposed to be rare at the time of their origin and they cannot increase from low frequencies in an unstructured habitat, consequently structured habitats are necessary for the evolution of bacteriocin [40]. Therefore, it could be hypothesized that bacteriocin production exists because of iota toxin which allows the attachment of type E strains to enterocytes, a structured habitat.
The specialized adhesive properties of several species of Clostridium to enterocytes and the synthesis of inhibitory substances seem most likely to be an adaptive response to a variety of factors present in a complex and competitive medium like the gut environment. These characteristics would facilitate the development of clonal populations, observed in natural cases of enteritis due to C. perfringens type E [7, 23]. However, it remains to be elucidated the connection between initial attachment with the damage observed in sick animals, particularly if iota toxin only facilitates the bacteria attachment or it is also responsible for the enteritis and associated epithelial damage observed in natural cases of type E disease. Further work is necessary to define the predisposing factor that would increase the damage produced after C. perfringens type E colonization in bovine intestine.
Supporting Information
Acknowledgments
This research was supported by Instituto Nacional de Tecnología Agropecuaria Grant INTA AESA-203941 and ANPCyT PICT 08/0861.We also thank the Consejo Nacional de Investigaciones Científicas y Tecnológicas-Argentina for support. We thank, Ms. Laura Gonzales, Mr. Ignacio de la Fuente and Ms. Claudia Moreno for invaluable help at the lab. We also thank Mr. Fabián Tricárico from the Museo Argentino de Ciencias Naturales “Bernardino Rivadavia” for sample processing and SEM photographs. We thank Ms. Daniela Losada Eaton for her manuscript correction.
Data Availability
All relevant data are within the paper and its Supporting Information files.
Funding Statement
Funding for this work came from Instituto Nacional de Tecnología Agropecuaria Grant INTA AESA-203941 and ANPCyT PICT 08/0861 to MFM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Additonal support was provided by the Consejo Nacional de Investigaciones Científicas y Tecnológicas-Argentina.
References
- 1. McClane BA, Uzal FA, Fernandez Miyakawa ME, Lyerly DM, Wilkins TD. The enterotoxic clostridia In Dworkin M., Falkow S., Rosenberg E., Schleifer K.-H., & Stackebrandt E., Editors. The Prokaryotes: Springer US; 2006; pp. 698–752. 10.1007/0-387-30744-3 [DOI] [Google Scholar]
- 2. Songer JG. Clostridial enteric diseases of domestic animals. Clinical Microbiology Reviews. 1996; 9: 216–34. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3. Li J, Miyamoto K, McClane BA. Comparison of virulence plasmids among Clostridium perfringens type E isolates. Infection and Immunity. 2007; 75: 1811–9. 10.1128/IAI.01981-06 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4. Baskerville M, Wood M, Seamer JH. Clostridium perfringens type E enterotoxaemia in rabbits. Veterinary Record. 1980; 107: 18–19. [DOI] [PubMed] [Google Scholar]
- 5. Hart B, Hooper PT. Enterotoxamemia of calves due to Clostridium welchii type E. Australian Veterinary Journal. 1967; 43: 360–363. 10.1111/j.1751-0813.1967.tb04882.x [DOI] [PubMed] [Google Scholar]
- 6. Songer JG, Miskimmins DW. Clostridium perfringens type E enteritis in calves: two cases and a brief review of the literature. Anaerobe. 2004; 10: 239–42. 10.1016/j.anaerobe.2004.05.001 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7. Redondo LM, Farber M, Venzano A, Jost BH, Parma YR, Fernandez-Miyakawa ME. Sudden death syndrome in adult cows associated with Clostridium perfringens type E. Anaerobe. 2013; 20: 1–4. 10.1016/j.anaerobe.2013.01.001 [DOI] [PubMed] [Google Scholar]
- 8. Kim HY, Byun JW, Roh IS, Bae YC, Lee MH, Kim B, et al. First isolation of Clostridium perfringens type E from a goat with diarrhea. Anaerobe. 2013; 22: 141–143. 10.1016/j.anaerobe.2013.06.009 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9. Kokai-Kun JF, Songer JG, Czeczulin JR, Chen F, McClane BA. Comparison of Western immunoblots and gene detection assays for identification of potentially enterotoxigenic isolates of Clostridium perfringens. J. Clin. Microbiol. 1994; 32: 2533–2539. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10. Sipos W, Fischer L, Schindler M, Schmoll F. Genotyping of Clostridium perfringens isolated from domestic and exotic ruminants and swine. Journal of Veterinary Medicine. B, Infectious Diseases and Veterinary Public Health. 2003; 50: 360–2. [DOI] [PubMed] [Google Scholar]
- 11. Carman R, Borriello S. Alternative animal models of Clostridium spiroforme mediated diarrhoea of rabbits. Microbial Ecology in Health and Disease. 1989; 2: 69–73. [Google Scholar]
- 12. Papatheodorou P, Carette JE, Bell GW, Schwan C, Guttenberg G, Brummelkamp TR, et al. Lipolysis-stimulated lipoprotein receptor (LSR) is the host receptor for the binary toxin Clostridium difficile transferase (CDT). Proceedings of the National Academy of Sciences of the United States of America. 2011; 108: 16422–7. 10.1073/pnas.1109772108 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13. Papatheodorou P, Wilczek C, Nölke T, Guttenberg G, Hornuss D, Schwan C, et al. Identification of the cellular receptor of Clostridium spiroforme toxin. Infection and Immunity. 2012; 80: 1418–23. 10.1128/IAI.06378-11 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14. Simpson LL, Stiles BG, Zepeda HH, Wilkins TD. Molecular basis for the pathological actions of Clostridium perfringens iota toxin. Infection and Immunity. 1987; 55: 118–22. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15. Barth H, Aktories K, Popoff M, Stiles B. Binary bacterial toxins: biochemistry, biology, and applications of common Clostridium and Bacillus proteins. Microbiology and Molecular Biology Reviews. 2004; 68: 373–402. 10.1128/MMBR.68.3.373 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16. Ohishi I, Iwasaki M, Sakaguchi G. Purification and characterization of two components of botulinum C2 toxin. Infect. Immun. 1980; 30:, 668–673. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17. Popoff MR, Milward FW, Bancillon B, Boquet P. Purification of the Clostridium spiroforme binary toxin and activity of the toxin on HEp-2 cells. Infect. Immun. 1989; 57: 2462–2469. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18. Rupnik M, Grabnar M, Geric B. Binary toxin producing Clostridium difficile strains. Anaerobe. 2003; 9: 289–294. [DOI] [PubMed] [Google Scholar]
- 19. Schwan C, Stecher B, Tzivelekidis T, van Ham M, Rohde M, Hardt WD, et al. Clostridium difficile toxin CDT induces formation of microtubule-based protrusions and increases adherence of bacteria. PLoS Pathogens. 2009; 5: e1000626 10.1371/journal.ppat.1000626 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20. Schwan C, Kruppke AS, Nölke T, Schumacher L, Koch-Nolte F, Kudryashev M, et al. Clostridium difficile toxin CDT hijacks microtubule organization and reroutes vesicle traffic to increase pathogen adherence. Proceedings of the National Academy of Sciences of the United States of America. 2014; 111: 2313–8. 10.1073/pnas.1311589111 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21. Li J, McClane BA. Contributions of NanI Sialidase to Caco-2 Cell Adherence by Clostridium perfringens Type A and C Human Intestinal Disease Strains.Infection and immunity. 2014; 82: 4620–30. 10.1128/IAI.02322-14 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22. Martin TG, Smyth JA. The ability of disease and non-disease producing strains of Clostridium perfringens from chickens to adhere to extracellular matrix molecules and Caco-2 cells. Anaerobe. 2010; 16: 533–9. 10.1016/j.anaerobe.2010.07.003 [DOI] [PubMed] [Google Scholar]
- 23. Jost BH, Trinh H, Songer J. Clonal relationships among Clostridium perfringens of porcine origin as determined by multilocus sequence typing. Veterinary Microbiology. 2006; 116: 158–165. 10.1016/j.vetmic.2006.03.025 [DOI] [PubMed] [Google Scholar]
- 24. Timbermont L, Lanckriet A, Pasmans F, Haesebrouck F, Ducatelle R, Van Immerseel F. Intra-species growth-inhibition by Clostridium perfringens is a possible virulence trait in necrotic enteritis in broilers. Veterinary Microbiology. 2009; 137: 388–91. 10.1016/j.vetmic.2009.01.017 [DOI] [PubMed] [Google Scholar]
- 25. Timbermont L, De Smet L, Van Nieuwerburgh F, Parreira VR, Van Driessche G, Haesebrouck F, et al. Perfrin, a novel bacteriocin associated with netB positive Clostridium perfringens strains from broilers with necrotic enteritis. Veterinary Research. 2014; 45: 40 10.1186/1297-9716-45-40 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26. Marshall R. Rapid technique for the enumeration of Clostridium perfringens. Applied Microbiology. 1965; 13: 559–563. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27. Meer RR, Songer JG. Multiplex polymerase chain reaction assay for genotyping Clostridium perfringens. American Journal of Veterinary Research. 1997; 58: 702–5. [PubMed] [Google Scholar]
- 28. Li J, McClane BA. Further comparison of temperature effects on growth and survival of Clostridium perfringens type A isolates carrying a chromosomal or plasmid-borne enterotoxin gene. Applied and Environmental Microbiology. 2006; 72: 4561–8. 10.1128/AEM.00177-06 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29. Stiles BG, Wilkins TD. Purification and characterization of Clostridium perfringens iota toxin: dependence on two nonlinked proteins for biological activity. Infection and Immunity. 1986; 54: 683–8. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30. Parma YR, Chacana PA, Rogé A, Kahl A, Cangelosi A, Geoghegan P, et al. Antibodies anti-Shiga toxin 2 B subunit from chicken egg yolk: isolation, purification and neutralization efficacy. Toxicon: Official Journal of the International Society on Toxinology. 2011; 58: 380–8. 10.1016/j.toxicon.2011.07.009 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31. Barbara AJ, Trinh HT, Glock RD, Glenn Songer J. Necrotic enteritis-producing strains of Clostridium perfringens displace non-necrotic enteritis strains from the gut of chicks. Veterinary Microbiology. 2008; 126: 377–82. 10.1016/j.vetmic.2007.07.019 [DOI] [PubMed] [Google Scholar]
- 32. Mahony DE. Bacteriocin susceptibility of Clostridium perfringens: a provisional typing schema. Applied Microbiology. 1974; 28: 172–6. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33. Watson GN. The assessment and application of a bacteriocin typing scheme for Clostridium perfringens. The Journal of Hygiene 1985; 94: 69–79. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34. Riley MA, Wertz JE. Bacteriocins: evolution, ecology, and application. Annual Review of Microbiology. 2002; 56: 117–37. 10.1146/annurev.micro.56.012302.161024 [DOI] [PubMed] [Google Scholar]
- 35. Kerr B, Riley MA, Feldman MW, Bohannan BJM. Local dispersal promotes biodiversity in a real-life game of rock-paper-scissors. Nature. 2002; 418: 171–4. 10.1038/nature00823 [DOI] [PubMed] [Google Scholar]
- 36. Lenski RE, Riley MA. Chemical warfare from an ecological perspective. Proceedings of the National Academy of Sciences of the United States of America. 2002; 99: 556–8. 10.1073/pnas.022641999 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 37. Riley MA, Gordon DM. The ecological role of bacteriocins in bacterial competition. Trends in Microbiology. 1999; 7: 129–33. [DOI] [PubMed] [Google Scholar]
- 38. Miyamoto K, Yumine N, Mimura K, Nagahama M, Li J, McClane BA, et al. Identification of novel Clostridium perfringens type E strains that carry an iota toxin plasmid with a functional enterotoxin gene. PloS One,. 2011; 6: e20376 10.1371/journal.pone.0020376 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 39. Stiles BG, Pradhan K, Fleming JM, Samy RP, Barth H, Popoff MR. Clostridium and Bacillus Binary Enterotoxins: Bad for the Bowels, and Eukaryotic Being. Toxins. 2014; 6: 2626–2656. 10.3390/toxins6092626 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 40. Majeed H, Lampert A, Ghazaryan L, Gillor O. The weak shall inherit: bacteriocin-mediated interactions in bacterial populations. PloS One. 2013; 8: e63837 10.1371/journal.pone.0063837 [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Supplementary Materials
Data Availability Statement
All relevant data are within the paper and its Supporting Information files.